Evidence mapPaperPMID 41987192Full record

ArticleBioData mining2026

Early prediction of longitudinal treatment adherence in obstructive sleep apnea using machine learning approaches.

Máximo Domínguez-Guerrero, Daniel Álvarez, Verónica Barroso-García, María Fernández-Vaquerizo, Tomás Ruiz-Albi, Roberto Hornero

Abstract read
In one paragraph

Article in BioData mining, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Máximo Domínguez-GuerreroBiomedical Engineering Group, University of Valladolid, Valladolid, 47011, Spain. maximodg@uva.es.ORCID http://orcid.org/0009-0006-3517-2189
Daniel ÁlvarezBiomedical Engineering Group, University of Valladolid, Valladolid, 47011, Spain.
Verónica Barroso-GarcíaBiomedical Engineering Group, University of Valladolid, Valladolid, 47011, Spain.
María Fernández-VaquerizoBiomedical Engineering Group, University of Valladolid, Valladolid, 47011, Spain.
Tomás Ruiz-AlbiBiomedical Engineering Group, University of Valladolid, Valladolid, 47011, Spain.
Roberto HorneroBiomedical Engineering Group, University of Valladolid, Valladolid, 47011, Spain.

Funding

Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina CB19/01/00012Interreg VI-A Spain-Portugal (POCTEP) 2021-2027 Program 0043_NET4SLEEP_2_EMinisterio de Ciencia, Innovación y Universidades CPP2022-009735
6 · The paper itself

Abstract

backgroundContinuous Positive Airway Pressure (CPAP) is the most prescribed treatment for Obstructive Sleep Apnea (OSA), but adherence remains a critical challenge, especially long term. This study aims to predict CPAP adherence at 3, 6, and 12 months based on baseline patient status and usage data from initial 30 days of treatment.

resultsA retrospective cohort of 2180 patients was analyzed. Feature selection was performed using the maximum relevance minimum redundancy (mRMR) algorithm with bootstrapping. Three machine learning (ML) models were trained and evaluated: support vector machine (SVM), random forest (RF), and multilayer perceptron (MLP). A core subset of early CPAP usage variables (median nightly use, days of use, and 30-day adherence) emerged as the most relevant features across all timepoints. Each prediction window also revealed exclusive features, suggesting that adherence at different stages may be driven by distinct factors. At 3 months, MLP exhibited the strongest predictive capacity (kappa = 0.823, AUC = 0.910). At 6 months, RF and SVM models yielded the highest results (kappa = 0.727, AUC = 0.863), whereas at 12 months, RF consistently outperformed the other algorithms (kappa = 0.698, AUC = 0.849), underscoring its robustness in forecasting long-term adherence.

conclusionsOur results suggest that ML algorithms can effectively predict CPAP adherence using very short-term usage data. Accordingly, our models are able to provide efficient early identification of patients at risk of non-adherence in order to support personalized interventions, improve outcomes, and reduce the healthcare burden in OSA management.

Indexed as

CPAP adherenceMachine learningMultilayer perceptronObstructive sleep apneaRandom forestSupport vector machines

Identifiers

PMID41987192
PMCPMC13202768

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.